Showing 1 - 1 of 1
The COVID-19 pandemic has highlighted problems regarding scarcity of lifesaving medicines. During pandemics and epidemics, a sudden surge in demand for medicines is often unmatched on the supply side. Moreover, the same intellectual property rights that are supposed to incentivize their creation...
Persistent link: https://www.econbiz.de/10013288862